NANOROBOTICS MARKET ANALYSIS

Nanorobotics Market, By Type (Bio-Nanorobots, Nano-Surgery Robots, Magnetically Guided Nanorobots, Bacteria-Based Nanorobots, DNA-Based Nanorobots, and Molecular Nanorobots), By Application (Targeted Drug Delivery, Medical Imaging, Surgical Applications, Dental Applications, and Others), By End User (Hospitals & Clinics, Bio-Pharmaceutical industries, Research laboratories, and Others), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa)

Fund Raise:
In April 2023, Nanovery, a biotechnology research company, raised over £1.85 million (US$ 2.23) funding to help its quest to save more lives through more accurate testing for prostate cancer. Nanovery has developed a nanorobot platform to detect chronic illnesses such as prostate cancer and liver disease. Its new nanorobot advancements include technologies that will be applicable for detection across various sectors. These include life sciences, pre-clinical drug development, agriculture bio and food safety.
In March 2021, Bionaut Labs, a company developing nanorobots that can be used to deliver drugs to treat brain diseases, announced that it had received US$20 million in a funding round led by Silicon Valley venture capital giant Khosla Ventures and Santa Monica-based Upfront Ventures.

Spin Off:
In February 2023, Nanobots Therapeutics, a tech company that focuses on developing and commercializing MotionTx platform, is the spin-off recently created by the Institute of Bioengineering of Catalonia (IBEC) and the Catalan Institution for Research and Advanced Studies (ICREA) that proposes to develop a technology based on nanorobots with unique penetration capabilities in tumors